Ball Analyst Price Targets - Benzinga

Ball Corp

BALLNYSE

Trade with Public

Trade with Public

$59.57

0.010.02%

Dern. MÀJ: Oct 14, 11:41 AM

$58.89

-0.67-1.13%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

Ball Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ball (BALL).

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

12Buy

2Hold

Consensus RatingBuy# Analysts14Avg. Consensus PT$69Upside to Avg. PT+15.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	RBC Capital	Arun Viswanathan	PT Cut	Outperform	$77→$73
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$66→$63
Sep 18, 2026	JP Morgan	Jeffrey Zekauskas	Upgrade	Neutral→Overweight	$65
Aug 5, 2026	UBS	Joshua Spector	PT Raise	Neutral	$65→$66
Aug 5, 2026	Wells Fargo	Gabe Hajde	PT Raise	Overweight	$71→$72
Aug 5, 2026	JP Morgan	Jeffrey Zekauskas	Downgrade	Overweight→Neutral	$60→$65
Jul 14, 2026	B of A Securities	George Staphos	PT Raise	Buy	$70→$73
Jul 9, 2026	RBC Capital	Arun Viswanathan	PT Raise	Outperform	$75→$77
Jul 9, 2026	Citigroup	Anthony Pettinari	PT Cut	Buy	$73→$72
May 18, 2026	JP Morgan	Jeffrey Zekauskas	Upgrade	Neutral→Overweight	$60
May 6, 2026	UBS	Joshua Spector	PT Cut	Neutral	$66→$64
May 6, 2026	Wells Fargo	Gabe Hajde	PT Raise	Overweight	$70→$71
Apr 15, 2026	Truist Securities	Michael Roxland	PT Raise	Buy	$75→$77
Apr 13, 2026	Citigroup	Anthony Pettinari	PT Cut	Buy	$74→$73
Apr 1, 2026	Deutsche Bank	Hillary Cacanando	Initiate	Hold→Buy	$72
Mar 20, 2026	RBC Capital	Arun Viswanathan	PT Cut	Outperform	$74→$71
Feb 5, 2026	Citigroup	Anthony Pettinari	PT Raise	Buy	$67→$74
Feb 4, 2026	JP Morgan	Jeffrey Zekauskas	PT Raise	Neutral	$50→$60
Feb 4, 2026	Wells Fargo	Gabe Hajde	PT Raise	Overweight	$60→$70
Feb 4, 2026	Jefferies	Philip Ng	PT Raise	Buy	$64→$71

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Ball, Lowers Price Target to $73

RBC Capital analyst Arun Viswanathan maintains Ball (NYSE:BALL) with a Outperform and lowers the price target from $77 to $73.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Ball, Lowers Price Target to $63

UBS analyst Joshua Spector maintains Ball (NYSE:BALL) with a Neutral and lowers the price target from $66 to $63.

Benzinga Newsdesk

PRO
JP Morgan Upgrades Ball to Overweight, Maintains Price Target to $65

JP Morgan analyst Jeffrey Zekauskas upgrades Ball (NYSE:BALL) from Neutral to Overweight and maintains the price target from $65 to $65.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Ball, Raises Price Target to $66

UBS analyst Joshua Spector maintains Ball (NYSE:BALL) with a Neutral and raises the price target from $65 to $66.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Ball, Raises Price Target to $72

Wells Fargo analyst Gabe Hajde maintains Ball (NYSE:BALL) with a Overweight and raises the price target from $71 to $72.

Benzinga Newsdesk

Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.

Avi Kapoor